Couldn't agree more. Considering where this was w

Couldn't agree more. Considering where this was when I first found Cellceutix back in late 2011and started taking a position building it through 2012. This has been (and will be again) a great trading stock for years. The last year or so has been rough for investors that missed taking some off near the tops and have been averaging down over and over as capital allows. The reality is that this is so undervalued for the current pipeline that I can't help but shake my head. Even the wife wonders why I've been sticking it out for so long. Explaining to people about the malicious crap that happens to many companies, even on the big boards by The Street throwing false information or misleading guidance from Adam F*kstien thinking he knows what he's saying. I remind her of the pipeline and how the trials have been progressing, in my opinion this should be running close to $5 if not more.
Results will be what stuffs the manipulators back in the gutter where they belong. I know I'm rambling on. There are many tactics used to attempt to keep a company out of favor from the passing surfer on the net. What we know about management, who's running the show and results to date are the key confidence factors that matter.

Think that's all I have to say about that.